Showing results (191-200 of 589) with videos related to
Sort By:
Pageof 59
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 27, 2002
Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancerPaula G Fraenkel, Seward B Rutkove, Jean K Matheson, et al.JAMA Oncology|March 10, 2017
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized TrialNaomi B Haas, Judith Manola, Janice P Dutcher, et al.Clinical Genitourinary Cancer|May 13, 2021
Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients With Advanced Renal Cell Carcinoma in the TIVO-3 StudyMichael Szarek, Michael N Needle, Brian I Rini, et al.The Oncologist|February 6, 2025
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 studyMiguel Zugman, David F McDermott, Bernard J Escudier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanomaKeith T Flaherty, Sandra J Lee, Fengmin Zhao, et al.Cancer Medicine|October 11, 2017
High frequency of brain metastases after adjuvant therapy for high-risk melanomaWolfram E Samlowski, James Moon, Merle Witter, et al.Frontiers in Oncology|January 31, 2022
Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint TherapyAidan M Burke, Michael Carrasquilla, Walter C Jean, et al.Cancer|October 7, 2015
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinomaSekwon Jang, Chaoyi Zheng, Huei-Ting Tsai, et al.Seminars in Arthritis and Rheumatism|November 15, 2024
Musculoskeletal ultrasound characteristics of checkpoint inhibitor-associated inflammatory arthritisMazen Nasrallah, Greg Challener, Sara Schoenfeld, et al.Proceedings of the National Academy of Sciences of the United States of America|September 9, 2021
Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrantsLauren E Stopfer, Aaron S Gajadhar, Bhavin Patel, et al.Pageof 59